Literature DB >> 10669747

Cloning and characterization of SCHIP-1, a novel protein interacting specifically with spliced isoforms and naturally occurring mutant NF2 proteins.

L Goutebroze1, E Brault, C Muchardt, J Camonis, G Thomas.   

Abstract

The neurofibromatosis type 2 (NF2) protein, known as schwannomin or merlin, is a tumor suppressor involved in NF2-associated and sporadic schwannomas and meningiomas. It is closely related to the ezrin-radixin-moesin family members, implicated in linking membrane proteins to the cytoskeleton. The molecular mechanism allowing schwannomin to function as a tumor suppressor is unknown. In attempt to shed light on schwannomin function, we have identified a novel coiled-coil protein, SCHIP-1, that specifically associates with schwannomin in vitro and in vivo. Within its coiled-coil region, this protein is homologous to human FEZ proteins and the related Caenorhabditis elegans gene product UNC-76. Immunofluorescent staining of transiently transfected cells shows a partial colocalization of SCHIP-1 and schwannomin, beneath the cytoplasmic membrane. Surprisingly, immunoprecipitation assays reveal that in a cellular context, association with SCHIP-1 can be observed only with some naturally occurring mutants of schwannomin, or a schwannomin spliced isoform lacking exons 2 and 3, but not with the schwannomin isoform exhibiting growth-suppressive activity. Our observations suggest that SCHIP-1 interaction with schwannomin is regulated by conformational changes in schwannomin, possibly induced by posttranslational modifications, alternative splicing, or mutations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10669747      PMCID: PMC85353          DOI: 10.1128/MCB.20.5.1699-1712.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  60 in total

1.  Defects in neurofibromatosis 2 protein function can arise at multiple levels.

Authors:  D H Gutmann; R T Geist; H m Xu; J S Kim; S Saporito-Irwin
Journal:  Hum Mol Genet       Date:  1998-03       Impact factor: 6.150

2.  Localization and functional domains of the neurofibromatosis type II tumor suppressor, merlin.

Authors:  R J Shaw; A I McClatchey; T Jacks
Journal:  Cell Growth Differ       Date:  1998-04

3.  The product of the NF2 tumour suppressor gene localizes near the plasma membrane and is highly expressed in muscle cells.

Authors:  M A den Bakker; P H Riegman; R A Hekman; W Boersma; P J Janssen; T H van der Kwast; E C Zwarthoff
Journal:  Oncogene       Date:  1995-02-16       Impact factor: 9.867

4.  Expression of the neurofibromatosis 2 tumor suppressor gene product, merlin, in Schwann cells.

Authors:  S S Scherer; D H Gutmann
Journal:  J Neurosci Res       Date:  1996-12-01       Impact factor: 4.164

5.  Detection of cellular proteins that interact with the NF2 tumor suppressor gene product.

Authors:  H Takeshima; I Izawa; P S Lee; N Safdar; V A Levin; H Saya
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

6.  Merlin differs from moesin in binding to F-actin and in its intra- and intermolecular interactions.

Authors:  L Huang; E Ichimaru; K Pestonjamasp; X Cui; H Nakamura; G Y Lo; F I Lin; E J Luna; H Furthmayr
Journal:  Biochem Biophys Res Commun       Date:  1998-07-30       Impact factor: 3.575

7.  A clinical study of type 2 neurofibromatosis.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; V Newton; R Harris
Journal:  Q J Med       Date:  1992-08

8.  Predominant occurrence of somatic mutations of the NF2 gene in meningiomas and schwannomas.

Authors:  P Mérel; K Hoang-Xuan; M Sanson; A Moreau-Aubry; E K Bijlsma; C Lazaro; J P Moisan; F Resche; I Nishisho; X Estivill
Journal:  Genes Chromosomes Cancer       Date:  1995-07       Impact factor: 5.006

9.  Impairment of cell adhesion by expression of the mutant neurofibromatosis type 2 (NF2) genes which lack exons in the ERM-homology domain.

Authors:  H Koga; N Araki; H Takeshima; T Nishi; T Hirota; Y Kimura; M Nakao; H Saya
Journal:  Oncogene       Date:  1998-08-20       Impact factor: 9.867

10.  Analysis of mutations in the SCH gene in schwannomas.

Authors:  E K Bijlsma; P Merel; D A Bosch; A Westerveld; O Delattre; G Thomas; T J Hulsebos
Journal:  Genes Chromosomes Cancer       Date:  1994-09       Impact factor: 5.006

View more
  21 in total

1.  The PDGF signaling pathway controls multiple steroid-producing lineages.

Authors:  Jennifer Schmahl; Kamran Rizzolo; Philippe Soriano
Journal:  Genes Dev       Date:  2008-12-01       Impact factor: 11.361

2.  Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L.

Authors:  Rong Rong; Xiaoling Tang; David H Gutmann; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-14       Impact factor: 11.205

3.  Schwannomin-interacting Protein 1 Isoform IQCJ-SCHIP1 Is a Multipartner Ankyrin- and Spectrin-binding Protein Involved in the Organization of Nodes of Ranvier.

Authors:  Pierre-Marie Martin; Carmen Cifuentes-Diaz; Jérôme Devaux; Marta Garcia; Jocelyne Bureau; Sylvie Thomasseau; Esther Klingler; Jean-Antoine Girault; Laurence Goutebroze
Journal:  J Biol Chem       Date:  2016-12-15       Impact factor: 5.157

4.  Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein.

Authors:  Hansoo Lee; Donghwa Kim; Han C Dan; Eric L Wu; Tatiana M Gritsko; Chuanhai Cao; Santo V Nicosia; Erica A Golemis; Wanguo Liu; Domenico Coppola; Steven S Brem; Joseph R Testa; Jin Q Cheng
Journal:  Mol Cell Biol       Date:  2007-01-08       Impact factor: 4.272

5.  Schip1, a new upstream regulator of Hippo signaling.

Authors:  Hyung-Lok Chung; Kwang-Wook Choi
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

6.  The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V.

Authors:  S Agarwal; J U Kazi; S Mohlin; S Påhlman; L Rönnstrand
Journal:  Oncogene       Date:  2014-12-01       Impact factor: 9.867

7.  Transcriptional profiling of Wnt4 mutant mouse kidneys identifies genes expressed during nephron formation.

Authors:  M Todd Valerius; Andrew P McMahon
Journal:  Gene Expr Patterns       Date:  2008-02-09       Impact factor: 1.224

8.  Cloning of cDNA encoding a regeneration-associated muscle protease whose expression is attenuated in cell lines derived from Duchenne muscular dystrophy patients.

Authors:  Yuki Nakayama; Noriko Nara; Yukiko Kawakita; Yasuhiro Takeshima; Masayuki Arakawa; Masaki Katoh; Sumiyo Morita; Ken Iwatsuki; Kiyoko Tanaka; Shiki Okamoto; Toshio Kitamura; Naohiko Seki; Ryoichi Matsuda; Masafumi Matsuo; Kayoko Saito; Takahiko Hara
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

9.  Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.

Authors:  Adeboye O Osunkoya; Qiqin Yin-Goen; John H Phan; Richard A Moffitt; Todd H Stokes; May D Wang; Andrew N Young
Journal:  Hum Pathol       Date:  2009-08-19       Impact factor: 3.466

Review 10.  Phosphorylation of merlin regulates its stability and tumor suppressive activity.

Authors:  Keqiang Ye
Journal:  Cell Adh Migr       Date:  2007-10-22       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.